397 related articles for article (PubMed ID: 24321501)
1. Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.
Ornoy A; Koren G
Semin Fetal Neonatal Med; 2014 Jun; 19(3):188-94. PubMed ID: 24321501
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
3. Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?
Ornoy A; Koren G
Birth Defects Res; 2017 Jul; 109(12):898-908. PubMed ID: 28714608
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects.
Ornoy A; Koren G
Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):247-259. PubMed ID: 29345153
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors in pregnancy.
Bellissima V; Ververs TF; Visser GH; Gazzolo D
Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral risks of SSRIs in pregnancy: Comparing human and animal data.
Ornoy A
Reprod Toxicol; 2017 Sep; 72():191-200. PubMed ID: 28495514
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
Cantor Sackett J; Weller RA; Weller EB
Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
[TBL] [Abstract][Full Text] [Related]
9. [Selective serotonin reuptake inhibitors and pregnancy].
Hassanzadeh T; Pedersen LH; Videbech P
Ugeskr Laeger; 2014 Feb; 176(3):236-9. PubMed ID: 24629751
[TBL] [Abstract][Full Text] [Related]
10. Safety of selective serotonin reuptake inhibitors in pregnancy.
Alwan S; Friedman JM
CNS Drugs; 2009; 23(6):493-509. PubMed ID: 19480468
[TBL] [Abstract][Full Text] [Related]
11. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
[TBL] [Abstract][Full Text] [Related]
12. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
14. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
15. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
Malm H; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Weissman M; Wickramaratne P; Artama M; Gingrich JA; Sourander A
J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):359-66. PubMed ID: 27126849
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors and malformations: case closed?
Koren G; Nordeng HM
Semin Fetal Neonatal Med; 2013 Feb; 18(1):19-22. PubMed ID: 23228547
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
18. Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child.
Lebin LG; Novick AM
Curr Psychiatry Rep; 2022 Nov; 24(11):687-695. PubMed ID: 36181572
[TBL] [Abstract][Full Text] [Related]
19. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
Gentile S
Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
[TBL] [Abstract][Full Text] [Related]
20. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.
Grigoriadis S; Vonderporten EH; Mamisashvili L; Tomlinson G; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
BMJ; 2014 Jan; 348():f6932. PubMed ID: 24429387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
